Article
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.
NPJ systems biology and applications - 25 Mar 2024
Uechi Lisa, Vasudevan Swetha, Vilenski Daniela, Branciamore Sergio, Frankhouser David, O'Meally Denis, Meshinchi Soheil, Marcucci Guido, Kuo Ya-Huei, Rockne Russell, Kravchenko-Balasha Nataly
Abstract excerpt
Acute myeloid leukemia (AML) is prevalent in both adult and pediatric patients. Despite advances in patient categorization, the heterogeneity of AML remains a challenge. Recent studies have explored the use of gene expression data to enhance AML diagnosis and prognosis, however, alternative approaches rooted in physics and chemistry may provide another level of insight into AML transformation. Utilizing publicly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
